//choosewashingtonstate.com/wp-content/uploads/2012/10/sector-sub-lifesciences1.jpg

New discoveries. Revolutionary cures.

One of the largest biotech clusters in the United States, Washington offers investors, startups and industry innovators a unique environment where collaboration is the norm and bold ideas such as the use of synthetic scorpion venom to paint brain tumors, are changing the face of health care.

In many respects, it's an entrepreneurial space where startups open shop right across the street from major research facilities and new ideas are readily shared over lunch or a microbrew. This culture of innovation extends beyond the sector itself, leveraging new advances in the technology industry to rapidly prototype new devices and approaches, such as the use of augmented reality in the surgical suite and big data to find new treatments and even cures.
 

A rich history of innovation.

Over the years our ideas have revolutionized medicine, from the portable heart defibrillator and Medic One emergency response system to bone marrow transplantation, the Scribner Shunt and outpatient kidney dialysis centers.

Anchored by highly respected research institutions such as the Fred Hutchinson Cancer Research Center, Allen Institute, University of Washington and Pacific Northwest National Laboratory, the sector employs more than 36,000 researchers and support staff working at 140 biotech companies, 416 medical technology and life science companies, 126 digital and internet technology firms, and 106 academic, nonprofit research and support organizations.

Nearly 170 organizations in the state are promoting and improving global health through research, training, education and public awareness, including the Gates Foundation, which has committed more than $32.9 billion to support global health initiatives around the world. These organizations have forged nearly 2,000 partnerships around the globe, spearheading 5,000 projects in 151 countries.

One of the great things about Washington’s life science/global health sector is that there is plenty of room for growth. Two-person startups with fresh ideas can easily explore and innovate, tapping into the huge intellectual capital of researchers, scientists, doctors and graduate students in the region.

Venture capitalists and angels are always on the lookout for the next Washington State success story, such as Juno Therapeutics, which is examining ways to use human T-cells to re-engage the immune system, which could revolutionize the way doctors treat cancer.

Washington has had the distinct honor of being home to eight Nobel Prize winners in medicine, chemistry and physiology. The University of Washington recently ranked first in technologies licensed and commercialization agreements and over the last decade Washington State University and the University of Washington have launched more than 200 startups that leveraged their research outcomes.
 

Contact us today!

Washington is redefining the world of healthcare on a global scale. Life science/global health organizations thrive in Washington because of our excellent research capabilities, highly collaborative partnerships that blur the lines between life science and technology, our history of innovation and invention, and our dedication to health and wellness worldwide, giving hope where there once was none.

Give us a call at (206) 256-6100 or email us at moreinfo@choosewashington.com to learn more about our life sciences/global health sector and how you can become part of the future of healthcare in Washington State.

 

Maura Little, Director of Economic Development for the Life Science Sector - Phone: (206) 256-6107

Julie A. Bennion, Export Assistance Manager, Life Science & Global Health - Phone: (206) 256-6132

Share